Valneva SE (VALN) Asset Utilization Ratio (2022 - 2026)
Valneva SE (VALN) posted Asset Utilization Ratio of 0.36 for Q1 2026, little changed sequentially from 0.36 in Q4 2025, and down 3.21% YoY from 0.37 in Q1 2025.
Analysis
Valneva SE (VALN) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Valneva SE has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.36 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 3.21% year-over-year to 0.36 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.36 (down 3.21% YoY) and the FY2025 annual result came in at 0.37, up 7.45% from the prior year.
- Asset Utilization Ratio was little changed at 0.36 in Q1 2026 per VALN's latest filing, from 0.36 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.78 in Q3 2022 and troughed at 0.31 in Q2 2024.
- A 5-year average of 0.43 and a median of 0.37 in 2025 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 37.42% in 2023, down 48.03% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.56 in 2022, then tumbled by 43.71% to 0.31 in 2023, then rose by 2.35% to 0.32 in 2024, then advanced by 11.61% to 0.36 in 2025, then advanced by 0.14% to 0.36 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.36, 0.36, and 0.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | 0.38 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.38 |
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.33 |
| Sep 30, 2024 | 0.32 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.31 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | 0.57 |
| Mar 31, 2023 | 0.61 |
| Dec 31, 2022 | 0.56 |
| Sep 30, 2022 | 0.78 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.44 |